Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: BI 836845
RN: 1772617-17-0


  • Acts against IGF-1 and IGF-2.

    NCI: IGF ligand neutralizing antibody BI 836845. A humanized IgG1 insulin-like growth factor (IGF) monoclonal antibody targeting the IGF ligands 1 (IGF-1) and 2 (IGF-2), with potential antineoplastic activity. Upon administration, IGF ligand neutralizing antibody BI 836845 binds to both IGF-1 and IGF-2 and inhibits the binding of these ligands to their receptor, IGF-1R. This blocks the insulin growth factor (IGF) signaling pathway, which is upregulated in a number of cancer cell types and plays a key role in cancer cell proliferation and chemoresistance. In addition, BI 836845 prevents the binding of IGF-2 to insulin receptor variant A (IR-A), preventing its activation. Check for active clinical trials using this agent. (NCI Thesaurus)

Molecular Formula

  • Unspecified
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

  • BI 836845

Registry Numbers

CAS Registry Number

  • 1772617-17-0

System Generated Number

  • 1772617170